This challenges widespread clinical assumptions about cannabis for mental health conditions, where prescribing has often outpaced robust evidence. Clinicians need to recalibrate expectations and counseling approaches for patients seeking cannabis treatments for anxiety, depression, and PTSD.
A systematic review found insufficient high-quality evidence supporting medicinal cannabis effectiveness for anxiety, depression, or PTSD. The analysis highlighted methodological limitations in existing studies, including small sample sizes, short duration, and heterogeneous outcome measures. This aligns with the broader challenge in cannabis medicine where clinical use has preceded definitive randomized controlled trial evidence for many conditions.
โThis doesn’t surprise me clinically โ we’ve been treating these conditions with cannabis based more on patient reports and mechanistic rationale than gold-standard evidence. It’s a reminder that enthusiasm shouldn’t substitute for rigorous proof of efficacy.โ
๐ฌ Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan โ
Want to discuss this topic with other patients and caregivers? Join the forum discussion โ
Have thoughts on this? Share it:
FAQ
This News item was assembled from structured source metadata and pipeline scoring.